Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Account Payables

Amounts the company owes suppliers for goods and services received.

No reported Account Payables figures are available to summarize.

Account Payables history

Currency unavailable · from the balance sheet

No Account Payables data reported for this period type.

Account Payables vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Account Payables for KARD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CYTKCytokinetics, IncorporatedJun 2026$20.51M USD+26.4%-4.5%1.1%
NAMSNewAmsterdam Pharma Company N.V.Jun 2026$5.42M USD-8.0%-8.9%0.8%
TNYATenaya Therapeutics, Inc.Mar 2026$1.91M USD-62.2%-28.0%1.4%
IKTInhibikase Therapeutics, Inc.Mar 2026$1.59M USD-6.2%+0.2%0.9%
RNAAtrium Therapeutics, Inc.Mar 2026$807K USD——0.3%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-7.1%-6.7%0.9%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.